SCP0196
Myosin Light Chain Kinase Substrate
≥95% (HPLC), lyophilized
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
Empirische Formel (Hill-System):
C61H107N23O16
Molekulargewicht:
1418.65
UNSPSC-Code:
12352202
NACRES:
NA.32
Empfohlene Produkte
![[Leu15,Gly18]-Gastrin2-17](/deepweb/assets/sigmaaldrich/product/images/384/185/d3095ca6-fe9a-4e1c-b2e9-29ad2bd40c46/640/d3095ca6-fe9a-4e1c-b2e9-29ad2bd40c46.jpg)
product name
Myosin Light Chain Kinase Substrate (smooth muscle),
Assay
≥95% (HPLC)
Form
lyophilized
Zusammensetzung
Peptide Content, ≥62%
Lagerbedingungen
protect from light
Lagertemp.
−20°C
Amino Acid Sequence
Lys-Lys-Arg-Ala-Ala-Arg-Ala-Thr-Ser-Asn-Val-Phe-Ala-NH2
Allgemeine Beschreibung
Myosin light chain kinase (MLCK) comprises an N-terminal actin-binding domain, a central kinase domain, and a C-terminal myosin-binding domain.
Anwendung
Myosin Light Chain Kinase Substrate (smooth muscle) has been used in MLCK activity assay to study the role of Plasmodium falciparum calmodulin (Pf CaM).
Biochem./physiol. Wirkung
KKRAARATSNVFA-NH2 is used as a myosin light chain kinase (MLCK) substrate.
Myosin light chain kinase (MLCK) is involved in modulating the actin-myosin interaction of smooth muscle. In addition to its kinase activity, MLCK also has actin-binding activity, which can assemble actin filaments into bundles. It also has myosin-binding activity, which can generate myosin filaments.
Lagerklassenschlüssel
11 - Combustible Solids
WGK
WGK 3
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Yevgeny Zolotarevsky et al.
Gastroenterology, 123(1), 163-172 (2002-07-10)
Maintenance of the mucosal barrier is a critical function of intestinal epithelia. Myosin regulatory light chain (MLC) phosphorylation is a common intermediate in the pathophysiologic regulation of this barrier. The aim of this study was to determine whether a membrane
A V Marchenko et al.
Biofizika, 55(6), 1008-1013 (2011-01-28)
The ability of novel cell-permeating peptide molecules derived from the peptide inhibitor of the myosin light chain kinase (MLCK) L-PIK (Arg-Lys-Lys-Tyr-Lys-Tyr-Arg-Arg-Lys) to inhibit this kinase in vitro and attenuate the thrombin-induced hyperpermeability of endothelial cell monolayer in culture has been
Haruhiko Ohtsu et al.
Arteriosclerosis, thrombosis, and vascular biology, 25(9), 1831-1836 (2005-07-05)
Rho and its effector Rho-kinase/ROCK mediate cytoskeletal reorganization as well as smooth muscle contraction. Recent studies indicate that Rho and ROCK are critically involved in vascular remodeling. Here, we tested the hypothesis that Rho/ROCK are critically involved in angiotensin II
A V Sekridova et al.
Bioorganicheskaia khimiia, 36(4), 498-504 (2010-09-09)
Myosin light chain kinase (MLCK) is the key regulator of various forms of cell motility including endothelial and epithelial permeability in particular. One of the potential MLCK inhibitors to be used in humans is a membrane permeable peptide H-RKKYKYRRK-NH2 (L-PIK).
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.